Photo from Kamil Erozkan/X
May 22, 2024, 07:46
Kamil Erozkan: Thrilled to present our study on TNT in early-stage rectal cancer at DDW 2024
Kamil Erozkan, Research Fellow at Cleveland Clinic, shared a post on X:
“Thrilled to present our study on TNT in early-stage rectal cancer at DDW 2024 (Digestive Disease Week).
- It was remarkable to achieve a 100% complete response rate.
- Reduced-dose TNT might be considered for future treatment plans.
Honored to work under the mentorship of Emre Gorgun.”
Source: Kamil Erozkan/X